LitAlert ~~ GeneLit.com

    • Clinical Utility of Liquid Biopsy to Identify Genomic Heterogeneity and Secondary Cancer Diagnoses: A Case Report.
    • Hemenway G, Tierno MB, Nejati R, Sosa R, Zibelman M.
    • Case Rep Oncol. 2022 Feb 7 [eCollection Jan-Apr 2022];15(1):78-85. doi: 10.1159/000521841.
    • Genetic Analysis of a Family with Multiple Incidences of Prostate Cancer.
    • Feng N, Liu F, Xu X, Wang Y, Sheng Q, Zhu K.
    • Case Rep Oncol. 2022 Feb 7 [eCollection Jan-Apr 2022];15(1):86-90. doi: 10.1159/000521122.
    • Mutational spectrum of breast cancer susceptibility genes among women ascertained in a cancer risk clinic in Northeast Brazil.
    • Felix GES, Santa Cruz Guindalini R, Zheng Y, Walsh T, Sveen E, Machado Lopes TM, Côrtes J, Zhang J, Carôzo P, Santos I, Ferreira Bonfim T, Garicochea B, Pereira Toralles MB, Meyer R, Netto EM, Abe-Sandes K, King MC, de Oliveira Nascimento IL, Olopade OI.
    • Breast Cancer Res Treat. 2022 Mar 30. doi: 10.1007/10.1007/s10549-022-06560-0. Epub ahead of print.
    • The Significant Predictors for Breast, Cervical, Colorectal, or Oral Cancer Screening Intention and Behavior in Taiwan.
    • Huang HC, Chang PC, Li SF, Wang CY, Huang WT, Chen W, Fan SY.
    • Cancer Nurs. 2022 Mar 29. doi: 10.1097/NCC.0000000000001107. Epub ahead of print.
    • Genetic Testing Challenges in Oncology: Doc Tells Patient With Familial Risks to Get DTC Testing.
    • Ray T.
    • Precision Oncology News. Cancer Specialties. 2022 Mar 29.
    • Awareness and Availability of Routine Germline BRCA1/2 Mutation Testing in Patients with Advanced Breast Cancer in Germany.
    • Lux MP, Decker T, Runkel ED, Niyazov A, Quek RGW, Marschner N, Harbeck N.
    • Breast Care (Basel). 2022 Feb;17(1):40-46. doi: 10.1159/000513596. Epub 2021 Feb 18.